[Study of non-hypophysiary growth retardation treated with formebolone].

Article Details

Citation
Copy to clipboard

Cuatrecasas Membrado JM, Bosch Banyeres JM

[Study of non-hypophysiary growth retardation treated with formebolone].

An Esp Pediatr. 1985 Jan;22(1):27-32.

PubMed ID
3985494 [ View in PubMed
]
Abstract

Results of a treatment with a derivative of androstane, named formebolone, are observed in 20 children (12 boys and eight girls), with non-pituitary growth retardation and normal values in hGH stimulation test. Initial heights were, most of them, far below--2 standard deviations and most bone ages showed more than two years retardation in comparison with the chronological ages. Results show a more significant height increase in pubertal cases as well as an acceleration of bone age that does not jeopardize final height.

DrugBank Data that Cites this Article

Drugs